Bioretec Ltd. has signed a distribution agreement for the U.S. market with Spartan Medical Inc. The agreement covers Bioretec's innovative RemeOs screws, manufactured from a proprietary biodegradable metal alloy, which received market authorization from the U.S. Food and Drug Administration (FDA) in March 2023. The signed distribution agreement signals the commencement of the rollout of the RemeOs screws in the United States. The agreement outlines the initiation of a controlled launch of the U.S. distribution of the RemeOs screws within strategically selected top-tier academic centers.

Additionally, the distribution agreement involves a potential to penetrate into the extensive U.S. Department of Defense and the Veterans Administration healthcare market.